Cancer Immunotherapy Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025


  • Rep Id : XPLREP4496
  • Published On : December, 2019
  • No. of Pages : 170
  • Category : Cancer

Cancer Immunotherapy Market – Scope of the Study

This report provides forecasts and analysis of the cancer immunotherapy market. This exclusive study also offers analytical data for the historical period (2016-2019) along with forecasts from 2020 to 2025 in terms of revenue (US$ Mn). The report on the global cancer immunotherapy market includes macroeconomic as well as microeconomic growth indicators. The study provides information on the key drivers and restraints influencing the growth of the cancer immunotherapy market, and their impact on each region during the forecast period. The report also comprises a study of the current challenges impeding the adoption rate and opportunities for manufacturers in the cancer immunotherapy market. This comprehensive study also includes value chain analysis, with a list of vendors and industry stakeholders at each node in the value chain, pipeline snapshot, and cancer epidemiology in every region.

In order to provide stakeholders with a comprehensive view of the cancer immunotherapy market, authors of the report have included detailed competitive analysis and key players with unique selling propositions. The dashboard provides a detailed comparison of manufacturers operating in the cancer immunotherapy market, on parameters such as collective market share and geographic concentration. This detailed study on the cancer immunotherapy market offers incisive insights regarding significant dynamics influencing the movement of the cancer immunotherapy landscape during the forecast period.

Authors of the cancer immunotherapy market report have taken ample care to track the latest market movements to ensure that only accurate information reaches to stakeholders. The study helps these stakeholders in gaining an edge over their competitors. This exclusive guide also tracks the current as well as future trends that are likely to influence the growth of the cancer immunotherapy market during the forecast period. To add to that, the analysis also discusses the threat of substitutes and new entrants, which provides a brief idea regarding the future growth course of the cancer immunotherapy market.

Cancer Immunotherapy Market – Assessment of Key Segments

The study encompasses market attractiveness analysis, by therapy, cancer type, end user, and region. Market size and forecasts for each segment have been provided in the context of global and regional markets. The cancer immunotherapy market has been analysed based on expected demand. All key end users have been considered, and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been considered while estimating the market for various end users of cancer immunotherapy in different regions.

Therapy

Cancer Type

End User

Region

Monoclonal Antibodies

Lung Cancer

Hospitals

North America

Immune Checkpoint Inhibitors

  • PD-1/PD-L1
  • CTLA-4

Colorectal Cancer

Ambulatory Surgical Centres

Europe

Immune System Modulators

Breast Cancer

Cancer Research Centres

Asia Pacific

Cancer Vaccines

Prostate Cancer

Clinics

Latin America

Others

Melanoma

 

Middle East & Africa

 

Blood Cancer

 

 

 

Others

 

 

The report provides a detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the key players in the global cancer immunotherapy market include Amgen, Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, GlaxoSmithKline Plc., F.Hoffmann-La Roche Ltd., Janssen Biotech, Inc., Novartis AG, Merck & Co., Inc., Pfizer, Inc., Spectrum Pharmaceuticals, Inc., Sanofi, and Takeda Pharmaceuticals.

Cancer Immunotherapy Market – Research Methodology

A number of primary and secondary sources were consulted during the course of the study on the cancer immunotherapy market. Secondary sources include NCBI, cancerresearch.org, WHO, FDA, Google Books, articles, company annual reports, websites, press releases, and publications.

The top-down approach has been used to estimate the cancer immunotherapy market by region. Market numbers for global therapy and therapeutic area segments have been derived using the bottom-up approach, which is cumulative of each region’s demand. Company-level market share has been derived on the basis of revenues reported by key players in the cancer immunotherapy market space. The cancer immunotherapy market has been forecast based on current currency rates.